351. Mobilization of calcium from intracellular store as a possible mechanism underlying the anti-opioid effect of angiotensin II.
- Author
-
Wang JF, Sun XJ, Yang HF, Ren MF, and Han JS
- Subjects
- Enkephalin, D-Penicillamine (2,5)-, Enkephalins pharmacology, Naloxone pharmacology, Neuroblastoma metabolism, Potassium Chloride pharmacology, Saralasin pharmacology, Tumor Cells, Cultured, Angiotensin II pharmacology, Calcium metabolism, Endorphins antagonists & inhibitors
- Abstract
Angiotensin II (AII), injected intracerebroventricularly, has been shown to antagonize opioid analgesia. The mechanism for this was obscure. In the neuroblastoma X glioma NG 108-15 hybrid cell line, the K(+)-induced increase in [Ca2+]i can be suppressed by the delta opioid agonist [D-Pen2, D-Pen5]enkephalin (DPDPE) at 0.01-1 microM, an effect completely reversed by the opioid antagonist naloxone. Angiotensin II (AII) at concentrations of 0.1 and 1 microM mobilized free Ca2+ from an intracellular pool, and this effect was antagonized by the AII receptor antagonist saralasin. All (1 microM) had no significant effect on the increase in [Ca2+]i induced by K+, but it blocked the suppressive effect of DPDPE on the K(+)-induced [Ca2+]i increase. The results indicate that mobilization of intracellular calcium may underlie the anti-opioid effect of AII.
- Published
- 1992
- Full Text
- View/download PDF